Ingalls & Snyder LLC Emergent Bio Solutions Inc. Transaction History

Ingalls & Snyder LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 27, 2021	SELL	$50.07 - $66.05 $168,685 - $222,522	-3,369 Closed	0 $0
Q2 2021 Aug 03, 2021	BUY	$56.61 - $80.46 $51,062 - $72,574	902 Added 36.56%	3,369 $212,000
Q1 2021 Apr 21, 2021	SELL	$86.23 - $125.19 $3,966 - $5,758	-46 Reduced 1.83%	2,467 $229,000
Q4 2020 Jan 27, 2021	SELL	$79.17 - $111.47 $82,336 - $115,928	-1,040 Reduced 29.27%	2,513 $225,000
Q3 2020 Oct 21, 2020	BUY	$81.91 - $134.94 $291,026 - $479,441	3,553 New	3,553 $367,000

160

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $438M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Ingalls & Snyder LLC, based on Form 13F filings with the SEC.

Stay updated on Ingalls & Snyder LLC with notifications on news.